Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Inogen IncINGN · Entity 2083 | Director | September 15, 2021 | September 17, 2021 |
| TACTILE SYSTEMS TECHNOLOGY INCTCMD · Entity 5451 | Director | May 06, 2026 | May 08, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Inogen Inc
Report date September 15, 2021 · Filed September 17, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 17,583 |
Ending reported balance
After 2021-09-15 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2021-09-15 · Exercise / conversion · Acquired 4,000 · Balance 21,583 Row 2 · 2021-09-15 · Sale · Disposed 4,000 · Balance 17,583 F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.54 · Expires 2022-05-15 | Direct | 11,806 |
Reported balance
After 2021-09-15 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-09-15 · Exercise / conversion · Disposed 4,000 · Balance 11,806 F2: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option was May 1, 2015. |
Filing footnotes · ownership attribution and instrument terms
F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021.
F2: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option was May 1, 2015.
TACTILE SYSTEMS TECHNOLOGY INC
Report date May 06, 2026 · Filed May 08, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 62,841 |
Reported balance
After 2026-05-06 transaction · row 1
1 source rowRow 1 · 2026-05-06 · Grant · Acquired 6,521 · Balance 62,841 F1: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units will vest in full on the earlier of one year from the grant date or the date of the next year's annual meeting of the stockholders.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
INTRICON CORP
Report date May 24, 2022 · Filed May 25, 2022
Section 16 reporting ended · disclosed 2022-05-25. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2022-05-24 transaction · row 1
1 source rowRow 1 · 2022-05-24 · Disposition to issuer · Disposed 11,154 · Balance 0 F1: Disposed of pursuant to an Agreement and Plan of Merger, dated as of February 27, 2022 (the "Merger Agreement") by and among the Issuer, IIN Holding Company Inc., a Delaware corporation ("Parent"), and IC Merger Sub Inc., a Pennsylvania corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. Each share of common stock exchanged in the Merger will receive cash of $24.25 per share. |
Filing footnotes · ownership attribution and instrument terms
F1: Disposed of pursuant to an Agreement and Plan of Merger, dated as of February 27, 2022 (the "Merger Agreement") by and among the Issuer, IIN Holding Company Inc., a Delaware corporation ("Parent"), and IC Merger Sub Inc., a Pennsylvania corporation and a wholly-owned subsidiary of Parent ("Merger Sub"), pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving the Merger as a wholly-owned subsidiary of Parent. Each share of common stock exchanged in the Merger will receive cash of $24.25 per share.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 14, 2018 Filed Dec 18, 2018 16:52 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,550 | $131.62 | $204,011.00 |
DisclosureSEC source: 0001209191-18-063089 · doc4.xml · nonDerivative · entry 7 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,797 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on [insert date]. F5 · price: Represents the weighted average share price of an aggregate total of 1,550 shares sold in the price range of $131.59 to $132.21 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 16:52 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 3,252 | $130.95 | $425,849.40 |
DisclosureSEC source: 0001209191-18-063089 · doc4.xml · nonDerivative · entry 6 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,347 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on [insert date]. F4 · price: Represents the weighted average share price of an aggregate total of 3,252 shares sold in the price range of $130.50 to $131.24 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 16:52 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,878 | $130.12 | $244,365.36 |
DisclosureSEC source: 0001209191-18-063089 · doc4.xml · nonDerivative · entry 5 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,599 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on [insert date]. F3 · price: Represents the weighted average share price of an aggregate total of 1,878 shares sold in the price range of $129.64 to $130.49 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 16:52 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,820 | $128.88 | $234,561.60 |
DisclosureSEC source: 0001209191-18-063089 · doc4.xml · nonDerivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,477 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on [insert date]. F2 · price: Represents the weighted average share price of an aggregate total of 1,820 shares sold in the price range of $128.51 to $129.49 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 16:52 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $38.54 | $96,350.00 |
DisclosureSEC source: 0001209191-18-063089 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 16:52 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCiommon Stock | 2,500 | $44.19 | $110,475.00 |
DisclosureSEC source: 0001209191-18-063089 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 14, 2018 Filed Dec 18, 2018 16:52 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 3,500 | $16.62 | $58,170.00 |
DisclosureSEC source: 0001209191-18-063089 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:33 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-18-059192 · doc4.xml · derivative · entry 12 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,800 Underlying: Common Stock · 2,500 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2016. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:33 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 2,500 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-18-059192 · doc4.xml · derivative · entry 11 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,400 Underlying: Common Stock · 2,500 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:33 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock (Right to Buy) · Derivative | 4,569 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-18-059192 · doc4.xml · derivative · entry 10 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,087 Underlying: Common Stock · 4,569 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:33 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 800 | $131.64 | $105,312.00 |
DisclosureSEC source: 0001209191-18-059192 · doc4.xml · nonDerivative · entry 9 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,797 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on [insert date]. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:33 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,933 | $130.36 | $251,985.88 |
DisclosureSEC source: 0001209191-18-059192 · doc4.xml · nonDerivative · entry 8 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,597 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on [insert date]. F5 · price: Represents the weighted average share price of an aggregate total of 1,933 shares sold in the price range of $130.07 to $130.51 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:33 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 3,868 | $129.20 | $499,745.60 |
DisclosureSEC source: 0001209191-18-059192 · doc4.xml · nonDerivative · entry 7 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,530 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on [insert date]. F4 · price: Represents the weighted average share price of an aggregate total of 3,868 shares sold in the price range of $129.01 to $130.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:33 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,728 | $128.66 | $222,324.48 |
DisclosureSEC source: 0001209191-18-059192 · doc4.xml · nonDerivative · entry 6 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,398 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on [insert date]. F3 · price: Represents the weighted average share price of an aggregate total of 1,728 shares sold in the price range of $128.35 to $129.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:33 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,240 | $127.34 | $157,901.60 |
DisclosureSEC source: 0001209191-18-059192 · doc4.xml · nonDerivative · entry 5 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,126 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on [insert date]. F2 · price: Represents the weighted average share price of an aggregate total of 1,240 shares sold in the price range of $127.26 to $128.00 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:33 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $38.54 | $96,350.00 |
DisclosureSEC source: 0001209191-18-059192 · doc4.xml · nonDerivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:33 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $44.19 | $110,475.00 |
DisclosureSEC source: 0001209191-18-059192 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:33 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 3,500 | $16.62 | $58,170.00 |
DisclosureSEC source: 0001209191-18-059192 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,366 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 21:33 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,069 | $16.62 | $17,766.78 |
DisclosureSEC source: 0001209191-18-059192 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,866 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2018 Filed Oct 18, 2018 00:33 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-18-055474 · doc4.xml · derivative · entry 14 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,300 Underlying: Common Stock · 2,500 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2016. Read SEC document |
| October 15, 2018 Filed Oct 18, 2018 00:33 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-18-055474 · doc4.xml · derivative · entry 13 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,900 Underlying: Common Stock · 2,500 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| October 15, 2018 Filed Oct 18, 2018 00:33 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 4,500 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-18-055474 · doc4.xml · derivative · entry 12 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,656 Underlying: Common Stock · 4,500 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. Read SEC document |
| October 15, 2018 Filed Oct 18, 2018 00:33 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-18-055474 · doc4.xml · derivative · entry 11 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,000 shares Expires 2023-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is October 1, 2013. Read SEC document |
| October 15, 2018 Filed Oct 18, 2018 00:33 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 340 | $200.14 | $68,047.57 |
DisclosureSEC source: 0001209191-18-055474 · doc4.xml · nonDerivative · entry 10 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,797 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F7 · price: Represents the weighted average share price of an aggregate total of 340 shares sold in the price range of $199.80 to $200.69 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 15, 2018 Filed Oct 18, 2018 00:33 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 360 | $198.71 | $71,535.38 |
DisclosureSEC source: 0001209191-18-055474 · doc4.xml · nonDerivative · entry 9 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,137 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F6 · price: Represents the weighted average share price of an aggregate total of 360 shares sold in the price range of $198.51 to $199.27 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 15, 2018 Filed Oct 18, 2018 00:33 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,440 | $197.85 | $284,901.41 |
DisclosureSEC source: 0001209191-18-055474 · doc4.xml · nonDerivative · entry 8 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,497 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F5 · price: Represents the weighted average share price of an aggregate total of 1,440 shares sold in the price range of $197.38 to $198.37 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 15, 2018 Filed Oct 18, 2018 00:33 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 3,796 | $196.89 | $747,376.60 |
DisclosureSEC source: 0001209191-18-055474 · doc4.xml · nonDerivative · entry 7 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,937 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F4 · price: Represents the weighted average share price of an aggregate total of 3,796 shares sold in the price range of $196.31 to $197.22 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 15, 2018 Filed Oct 18, 2018 00:33 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 3,174 | $195.87 | $621,702.81 |
DisclosureSEC source: 0001209191-18-055474 · doc4.xml · nonDerivative · entry 6 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,733 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F3 · price: Represents the weighted average share price of an aggregate total of 3,174 shares sold in the price range of $195.30 to $196.25 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 15, 2018 Filed Oct 18, 2018 00:33 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,390 | $194.96 | $270,996.07 |
DisclosureSEC source: 0001209191-18-055474 · doc4.xml · nonDerivative · entry 5 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,907 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F2 · price: Represents the weighted average share price of an aggregate total of 1,390 shares sold in the price range of $194.27 to $195.15 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| October 15, 2018 Filed Oct 18, 2018 00:33 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $44.19 | $110,475.00 |
DisclosureSEC source: 0001209191-18-055474 · doc4.xml · nonDerivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2018 Filed Oct 18, 2018 00:33 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $38.54 | $96,350.00 |
DisclosureSEC source: 0001209191-18-055474 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2018 Filed Oct 18, 2018 00:33 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 4,500 | $16.62 | $74,790.00 |
DisclosureSEC source: 0001209191-18-055474 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 15, 2018 Filed Oct 18, 2018 00:33 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,000 | $8.37 | $8,370.00 |
DisclosureSEC source: 0001209191-18-055474 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 00:00 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-18-051296 · doc4.xml · derivative · entry 15 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,800 Underlying: Common Stock · 2,500 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F12 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2016. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 00:00 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-18-051296 · doc4.xml · derivative · entry 14 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,400 Underlying: Common Stock · 2,500 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 00:00 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 4,500 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001209191-18-051296 · doc4.xml · derivative · entry 13 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,156 Underlying: Common Stock · 4,500 shares Expires 2021-03-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 00:00 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 1,000 | $0.00 Strike: $8.37 | $0.00 |
DisclosureSEC source: 0001209191-18-051296 · doc4.xml · derivative · entry 12 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2023-10-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: Subject to the reporting person's continuing service, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is October 1, 2013. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 00:00 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 640 | $285.28 | $182,577.41 |
DisclosureSEC source: 0001209191-18-051296 · doc4.xml · nonDerivative · entry 11 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,797 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F8 · price: Represents the weighted average share price of an aggregate total of 640 shares sold in the price range of $285.14 to $285.39 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 00:00 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,751 | $284.63 | $498,381.18 |
DisclosureSEC source: 0001209191-18-051296 · doc4.xml · nonDerivative · entry 10 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,437 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F7 · price: Represents the weighted average share price of an aggregate total of 1,751 shares sold in the price range of $284.11 to $285.10 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 00:00 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 1,095 | $283.63 | $310,576.05 |
DisclosureSEC source: 0001209191-18-051296 · doc4.xml · nonDerivative · entry 9 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,188 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F6 · price: Represents the weighted average share price of an aggregate total of 1,095 shares sold in the price range of $283.06 to $284.02 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 00:00 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 3,140 | $282.60 | $887,358.03 |
DisclosureSEC source: 0001209191-18-051296 · doc4.xml · nonDerivative · entry 8 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,283 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F5 · price: Represents the weighted average share price of an aggregate total of 3,140 shares sold in the price range of $282.05 to $283.04 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 00:00 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 2,374 | $281.50 | $668,282.42 |
DisclosureSEC source: 0001209191-18-051296 · doc4.xml · nonDerivative · entry 7 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,423 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F4 · price: Represents the weighted average share price of an aggregate total of 2,374 shares sold in the price range of $281.04 to $282.02 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 00:00 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 596 | $280.53 | $167,196.65 |
DisclosureSEC source: 0001209191-18-051296 · doc4.xml · nonDerivative · entry 6 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,797 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F3 · price: Represents the weighted average share price of an aggregate total of 596 shares sold in the price range of $280.025 to $281.010 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 00:00 UTC | Inogen Inc INGN · Entity 2083 | SaleCommon Stock | 904 | $279.47 | $252,638.89 |
DisclosureSEC source: 0001209191-18-051296 · doc4.xml · nonDerivative · entry 5 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,393 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 2, 2018. F2 · price: Represents the weighted average share price of an aggregate total of 904 shares sold in the price range of $279.00 to $279.96 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 00:00 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $44.19 | $110,475.00 |
DisclosureSEC source: 0001209191-18-051296 · doc4.xml · nonDerivative · entry 4 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 00:00 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 2,500 | $38.54 | $96,350.00 |
DisclosureSEC source: 0001209191-18-051296 · doc4.xml · nonDerivative · entry 3 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 00:00 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 4,500 | $16.62 | $74,790.00 |
DisclosureSEC source: 0001209191-18-051296 · doc4.xml · nonDerivative · entry 2 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,297 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2018 Filed Sep 18, 2018 00:00 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionCommon Stock | 1,000 | $8.37 | $8,370.00 |
DisclosureSEC source: 0001209191-18-051296 · doc4.xml · nonDerivative · entry 1 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 00:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $44.19 | $0.00 |
DisclosureSEC source: 0001209191-18-047223 · doc4.xml · derivative · entry 14 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,300 Underlying: Common Stock · 2,500 shares Expires 2023-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the shares subject to the option shall vest each month on the same day as the vesting commencement date, such that the shares subject to the option shall become fully vested and exercisable on the fourth (4th) anniversary of the vesting commencement date. The vesting commencement date for this option is May 1, 2016. Read SEC document |
| August 15, 2018 Filed Aug 17, 2018 00:24 UTC | Inogen Inc INGN · Entity 2083 | Exercise / conversionStock Option (right to buy) · Derivative | 2,500 | $0.00 Strike: $38.54 | $0.00 |
DisclosureSEC source: 0001209191-18-047223 · doc4.xml · derivative · entry 13 Huggenberger Raymond · CIK 0001596078 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,900 Underlying: Common Stock · 2,500 shares Expires 2022-05-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F10 · derivative.exercise_date: Subject to the reporting person's continuing service, twenty-five percent (25%) of the shares subject to the option shall vest and become exercisable on the one year anniversary of the vesting commencement date, and thereafter, one forty-eighth (1/48th) of the total shares subject to the option shall vest each month on the same day as the vesting commencement date. The vesting commencement date for this option is May 1, 2015. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.